Genetic abnormalities in Fibrodysplasia ossificans progressiva

Genes and Genetic Systems

Volumn 87, Issue 4, 2012, Pages 213-219

  Miao, Jinglei ^a   Zhang, Chaoyue ^a   Wu, Song ^a   Peng, Zhi ^a   Tania, Mousumi ^b  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ACVR1 gene; Bone morphogenetic proteins; NOG gene; Paternal age effect

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN RECEPTOR; CORTICOSTEROID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOGGIN; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ACTIVIN RECEPTOR TYPE IA GENE; AMINO ACID SUBSTITUTION; CHROMOSOME 17Q; CHROMOSOME 3Q; DIAGNOSTIC ERROR; DISEASE EXACERBATION; DRUG MEGADOSE; EARLY DIAGNOSIS; GENE; GENE MUTATION; HETEROTOPIC OSSIFICATION; HETEROZYGOTE; HUMAN; NOGGIN GENE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; OSSIFYING MYOSITIS; PATERNAL AGE; POINT MUTATION; REVIEW; RNA INTERFERENCE;

EID: 84871203029     PISSN: 13417568     EISSN: 18805779     Source Type: Journal    
DOI: 10.1266/ggs.87.213     Document Type: Review

References (49)

1. Ahn, J., Feldman, G., Terry, L., Shore, E. M., and Kaplan, F. S. (2003) Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva. Clin. Orthop. Relat. Res. 406, 205-213.
2. Bocciardi, R., Bordo, D., Di Duca, M., Di Rocco, M., and Ravazzolo, R. (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur. J. Hum. Genet. 17, 311-318.
3. Carvalho, D. R., Navarro, M. M., Martins, B. J., Coelho, K. E., Mello, W. D., Takata, R. I., and Speck-Martins, C. E. (2010) Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients. Clin. Genet. 77, 171-176.
4. Chakkalakal, S. A., Zhang, D., Culbert, A. L., Convente, M. R., Caron, R. J., Wright, A. C., Maidment, A. D., Kaplan, F. S., and Shore, E. M. (2012) An ACVR1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J. Bone Miner. Res. 27, 1746-1756.
5. Connor, J. M., and Evans, D. A. (1982) Genetic aspects of fibrodysplasia ossificans progressiva. J. Med. Genet. 19, 35-39.
6. Du, J., Huang, L. L., Tan, Y. Q., Cheng, D. H., Li, S. F., Li, L. Y., and Lu, G. X. (2010) Mutation analysis and prenatal exclusion of fibrodysplasia ossificans progressiva in a Chinesefetus. Genet. Test. Mol. Biomarkers, 2010 Jan 10. [Epub ahead of print].
7. Dzukou, T., Barbier, C., Spyckerelle, C., Labarrière, F., Vittu, G., and Kremp, O. (2005) Fibrodysplasia ossificans progressiva in children. The interest of early diagnosis and treatment. Presse Med. 34, 373-377.
8. Feldman, G. J., Billings, P. C., Patel, R. V., Caron, R. J, Guenther, C., Kingsley, D. M., Kaplan, F. S., and Shore, E. M. (2007) Over-expression of BMP4 and BMP5 in a child with axial skeletal malformations and heterotopic ossification: a new syndrome. Am. J. Med. Genet. A. 143A, 699-706.
9. Fontaine, K., Sémonin, O., Legarde, J. P., Lenoir, G., and Lucotte, G. (2005) A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family. Genet. Couns. 16, 149-154.
10. Furuya, H., Ikezoe, K., Wang, L., Ohyagi, Y., Motomura, K., Fujii, N., Kira, J., and Fukumaki, Y. (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1mutation, G356D, other than the common mutation (R206H). Am. J. Med. Genet. A. 146A, 459-463.
11. Gannon, F. H., Kaplan, F. S., Olmsted, E., Finkel, G. C., Zasloff, M. A., and Shore, E. (1997) Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum. Pathol. 28, 339-343.
12. Gregson, C. L., Hollingworth, P., Williams, M., Petrie, K. A., Bullock, A. N., Brown, M. A., Tobias, J. H., and Triffitt, J. T. (2011) A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date. Bone 48, 654-658.
13. Kan, L., Hu, M., Gomes, W. A., and Kessler, J. A. (2004) Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am. J. Pathol. 165, 1107-1115.
14. Kaplan, F. S., and Shore, E. M. (1998) Encrypted morphogens of skeletogenesis: biological errors and pharmacologic potentials. Biochem. Pharmacol. 55, 373-382.
15. Kaplan, F. S., Tabas, J. A., and Zasloff, M. A. (1990) Fibrodysplasia ossificans progressiva: a clue from the fly? Calcif. Tissue Int. 47, 117-125.
16. Kaplan, F. S., Tabas, J. A., Gannon, F. H., Finkel, G., Hahn, G. V., and Zasloff, M. A. (1993) The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J. Bone Joint Surg. Am. 75, 220-230.
17. Kaplan, F. S., Shore, E. M., Pignolo, R. J., and Glaser, D. L. (2005) Animal models of fibrodysplasia ossificans progressive. Clin. Rev. Bone Min. Met. 3, 229-234.
18. Kaplan, F. S., Fiori, J., DE LA Peña, L. S., Ahn, J., Billings, P. C., and Shore, E. M. (2006) Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva.Ann. N. Y. Acad. Sci. 1068, 54-65.
19. Kaplan, F. S., Glaser, D. L., Pignolo, R. J., and Shore, E. M. (2007) A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin. Biol. Ther. 7, 705-712.
20. Kaplan, F. S., Le Merrer, M., Glaser, D. L., Pignolo, R. J., Goldsby, R. E., Kitterman, J. A., Groppe, J., and Shore, E. M. (2008) Fibrodysplasia ossificans progressiva. Best Pract. Res. Clin. Rheumatol. 22, 191-205.
21. Kaplan, F. S., Zasloff, M. A., Kitterman, J. A., Shore, E. M., Hong, C. C., and Rocke, D. M. (2010) Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J. Bone Joint Surg. Am. 92, 686-691.
22. Kaplan, J., Kaplan, F. S., and Shore, E. M. (2012) Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting. Gene Ther. 19, 786-790.
23. Kartal-Kaess, M., Shore, E. M., Xu, M., Schwering, L., Uhl, M., Korinthenberg, R., Niemeyer, C., Kaplan, F. S., and Lauten, M. (2010) Fibrodysplasia ossificans progressiva (FOP): watch the great toes! Eur. J. Pediatr. 169, 1417-1421.
24. Katagiri, T., Kamizono, J., Nakashima, Y., Kitoh, H., Susami, T., and Haga, N. (2010) Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva. Clin. Calcium. 20, 1510-1517.
25. Kitterman, J. A., Kantanie, S., Rocke, D. M., and Kaplan, F. S. (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 116, e654-e661.
26. Lee, D. Y., Cho, T. J., Lee, H. R., Park, M. S., Yoo, W. J., Chung, C. Y., and Choi, I. H. (2009) ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J. Korean Med. Sci. 24, 433-437.
27. Levy, C. E., Lash, A. T., Janoff, H. B., and Kaplan, F. S. (1999) Conductive hearing loss in individuals with fibrodysplasia ossificans progressiva. Am. J. Audiol. 8, 29-33.
28. Lin, G. T., Chang, H. W., Liu, C. S., Huang, P. J., Wang, H. C., and Cheng, Y. M. (2006) De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. J. Hum. Genet. 51, 1083-1086.
29. Lucotte, G., Bathelier, C., Mercier, G., Gérard, N., Lenoir, G., Sémonin, O., and Fontaine, K. (2000) FOP Consortium. Fibrodysplasia Ossificans Progressiva Consortium. Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22. Genet. Couns. 11, 329-334.
30. Lucotte, G., Houzet, A., Hubans, C., Lagarde, J. P., and Lenoir, G. (2009) Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients. Genet. Couns. 20, 53-62.
31. Mahboubi, S., Glaser, D. L., Shore, E. M., and Kaplan, F. S. (2001) Fibrodysplasia ossificans progressiva. Pediatr. Radiol. 31, 307-314.
32. Nakajima, M., Haga, N., Takikawa, K., Manabe, N., Nishimura, G., and Ikegawa, S. (2007) The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. J. Hum. Genet. 52, 473-475.
33. NCBI GenBank (2012) http://www.ncbi.nlm.nih.gov/gene/90. Retrieved on September 12, 2012.
34. Petrie, K. A., Lee, W. H., Bullock, A. N., Pointon, J. J., Smith, R., Russell, R. G., Brown, M. A., Wordsworth, B. P., and Triffitt, J. T. (2009) Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS One 4, e5005.
35. Pignolo, R. J., Shore, E. M., and Kaplan, F. S. (2011) Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J. Rare Dis. 6, 80.
36. Ratbi, I., Borcciadi, R., Regragui, A., Ravazzolo, R., and Sefiani, A. (2010) Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Clin. Rheumatol. 29, 119-121.
37. Rogers, J. G., and Chase, G. A. (1979) Paternal age effect in fibrodysplasia ossificans progressiva. J. Med. Genet. 16, 147-148.
38. Sémonin, O., Fontaine, K., Daviaud, C., Ayuso, C., and Lucotte, G. (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am. J. Med. Genet. 102, 314-317.
39. Shen, Q., Little, S. C., Xu, M., Haupt, J., Ast, C., Katagiri, T., Mundlos, S., Seemann, P., Kaplan, F. S., Mullins, M. C., and Shore, E. M. (2009) The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J. Clin. Invest. 119, 3462-3472.
40. Shore, E. M., Gannon, F. H., and Kaplan, F. S. (1997) Fibrodysplasia ossificans progressiva why do some people have two skeletons? J. Clin. Rheumatol. 3, 84-89.
41. Shore, E. M. (2012) Fibrodysplasia ossificans progressiva (FOP): A human genetic disorder of extra-skeletal bone formation, or How does one tissue become another? Wiley Interdiscip.Rev. Dev. Biol. 1, 153-165.
42. Song, G. A., Kim, H. J., Woo, K. M., Baek, J. H., Kim, G. S., Choi, J. Y., and Ryoo, H. M. (2010) Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. J. Biol. Chem. 285, 22542-22553.
43. Song, H., Wang, Q., Wen, J., Liu, S., Gao, X., Cheng, J., and Zhang, D. (2012) ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. Int. J. Mol. Sci. 13, 2063-2077.
44. Sun, Y., Xia, W., Jiang, Y., Xing, X., Li, M., Wang, O., Zhang, H., Hu, Y., Liu, H., Meng, X., et al. (2009) A recurrent mutation c.617G>A in the ACVR1 gene causes fibrodysplasia ossificans progressiva in two Chinese patients. Calcif. Tissue Int. 84, 361-365.
45. Takahashi, M., Katagiri, T., Furuya, H., and Hohjoh, H. (2012) Disease-causing allele-specific silencing against the ALK2mutants, R206H and G356D, infibrodysplasia ossificans progressiva. Gene Ther. 19, 781-785.
46. Ulusoy, H. (2012) Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies. Rheumatol. Int. 32, 1379-1382.
47. Whyte, M. P., Wenkert, D., Demertzis, J. L., Dicarlo, E. F., Westenberg, E., and Mumm, S. (2012) Fibrodysplasia ossificans progressiva: Middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1. J. Bone Miner. Res. 27, 729-737.
48. Zaghloul, K. A., Heuer, G. G., Guttenberg, M. D., Shore, E. M., Kaplan, F. S., and Storm, P. B. (2008) Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva. J. Neurosurg. Pediatr. 1, 91-94.
49. Zhou, Q., Meng, Y., Su, L., Zhao, S. M., Shi, H. P., and Huang, S. Z. (2008) A Chinese girl with fibrodysplasia ossificans progressiva caused by a de novo mutation R206H in ACVR1gene. Zhonghua Er Ke Za Zhi. 46, 215-219.